Cancer Diagnosis News and Research

RSS

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

The ‘two week wait’ referral was brought into England in 2000. If a patient goes to see their GP and they meet specific criteria that cause the GP to think they might have cancer, then they should be referred to see a specialist within two weeks.

28 Oct 2015

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Researchers studying two generations of a family affected by pediatric acute lymphoblastic leukemia (ALL) have identified an inherited variation in the ETV6 gene that is associated with an increased risk of developing the disease. St. Jude Children's Research Hospital investigators led the study, which appears in the October 28 issue of the journal Lancet Oncology.

28 Oct 2015

Study uncovers new genetic variants linked to increased risk of testicular cancer

A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.

27 Oct 2015

UW researcher reveals how cancer diagnosis affects employment, income of individuals and families

A new analysis by University of Wyoming researcher Anna Zajacova indicates that when American adults are diagnosed with cancer, they experience significant decreases in the probability of working, in the number of hours they work and, correspondingly, in their incomes.

26 Oct 2015

Study describes successful intervention to decrease breast cancer screening anxiety

Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.

23 Oct 2015

University of Warwick, SYSUCC sign MoU to create cancer research partnership

The University of Warwick and Sun Yat-sen University Cancer Center have signed a Memorandum of Understanding (MoU) to create a research partnership in cancer diagnosis and specialist cancer care.

22 Oct 2015

New research seeks to improve understanding of how breast cancer starts

Dr Michalak was awarded a highly competitive, four-year career development fellowship from the National Breast Cancer Foundation for her research into breast stem cells. The funding is helping to further her research, which seeks to improve our understanding of how breast cancer starts.

20 Oct 2015

Lightpoint Medical's LightPath Imaging System now CE marked

Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that the LightPath Imaging System is now CE marked, enabling the launch of the device in Europe.

19 Oct 2015

Johns Hopkins members to be honored with American Academy of Nursing's Fellows recognition

Faculty members at the Johns Hopkins School of Nursing will be honored in all three categories of the American Academy of Nursing's Fellows recognition. Sharon Kozachik, PhD, RN, and Jennifer Wenzel, PhD, RN, CCM, will be inducted as Fellows, Laura Gitlin, PhD, will be awarded an Honorary fellowship, and Fannie Gaston-Johansson, PhD, RN, FAAN, will be recognized as a Living Legend—the academy's highest distinction.

16 Oct 2015

EKF’s PointMan™ used in cancer biopsy research

EKF, announces results from a study involving EKF Molecular’s PointMan™ DNA enrichment technology have been published in Clinical Cancer Research.

From EKF Diagnostics 15 Oct 2015

New blood test could help pair cancer patients with suitable therapy for their disease

CANCER RESEARCH UK-funded scientists have developed a blood test that could help pair cancer patients with the most suitable therapy for their disease and then track the tumour's progress to see if the treatment is working, according to research published today (Thursday) in Clinical Cancer Research.

15 Oct 2015

Ambry Genetics presents groundbreaking TP53 gene data at ASHG; TP53 linked to breast cancer

Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, has announced new data affirming the effectiveness of multi-gene panel testing (MGPT) in identifying TP53 gene mutations in people who might otherwise not have been tested. The findings, presented as a poster at the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore, includes data collected from more than 25,000 individuals having TP53 testing, of which 187 were positive. The tested cohort is the largest to date from a single testing laboratory.

9 Oct 2015

Jumping genes: a marker for early cancer diagnosis? An interview with Dr Kazazian

In the genome of every human being, there are about 80-100 active LINE-1s that are capable of mobilizing by a copy and paste mechanism to a new location in the genome.

6 Oct 2015

Oxford Gene Technology launches Cytocell FISH probe for bladder cancer

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ hybridisation (FISH) probe kit for non-invasive detection of bladder cancer — for sale in Europe.

From Oxford Gene Technology 6 Oct 2015

UT Southwestern announces launch of new health initiative

UT Southwestern Medical Center today announced the launch of "Call Out Cancer," a new health initiative designed to promote awareness, early detection, and prevention of all types of cancer.

6 Oct 2015

Testosterone therapy not associated with increased risk of aggressive prostate cancer: Study

A new population-based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive prostate cancer. Further, risk of high-grade prostate cancer did not increase according to the total number of testosterone injections.

5 Oct 2015

LDCT lung cancer screening does not lead to unnecessary treatment

Lung cancer screening programs that utilize standardized reporting and include cardiothoracic surgeons as part of a multidisciplinary team can successfully be adopted into clinical practice without an increase in surgical intervention for non-cancerous disease, according to an article in the October 2015 issue of The Annals of Thoracic Surgery.

1 Oct 2015

Cancer treatment does not affect pregnancy outcome, shows new study

Women who are pregnant when diagnosed with cancer can start treatment for their disease immediately and do not need to terminate their pregnancy due to worries over the effects of therapy on the development of their child.

29 Sep 2015

Study may lead to new insights on use of aspirin in GI cancer

Aspirin improves survival in patients with tumours situated throughout the gastrointestinal (GI) tract, results from a large study in The Netherlands show. This is the first time that survival data from patients with tumours in different GI locations have been analysed at the same time; previously, only one type of cancer, usually colorectal, was studied.

28 Sep 2015

Portuguese researchers find significant differences between smokers and non-smokers who develop NSCLC

Tobacco smoke is known to be the main risk factor for non-small cell lung cancer (NSCLC), although non-smokers can get it too. The incidence among non-smokers is increasing in many countries. Now a group of Portuguese researchers has found significant differences in clinical particularities and survival between smokers and non-smokers who develop NSCLC.